Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancer.
暂无分享,去创建一个
R. Vyzula | M. Campone | J. Jassem | O. Trédan | C. Pacilio | A. Hardy-Bessard | H. Roché | J. Prausová | B. Coudert | P. Mukhopadhyay | A. Arance | A. Aloe